LC–MS method for the estimation of Δ8-THC and 11-nor-Δ8-THC-9-COOH in plasma

Abstract The aim of the present study was to develop a simple and sensitive LC–MS method for the estimation of Δ 8 -tetrahydrocannabinol (Δ 8 -THC) and its metabolite, 11-nor-Δ 8 -tetrahydrocannabinol-9-carboxylic acid (11-nor-Δ 8 -THC-9-COOH), in guinea pig plasma after topical drug application. The plasma samples were analyzed by LC–MS using negative-mode electrospray ionization detection and a simple liquid–liquid extraction technique. The mean recoveries for Δ 8 -THC and its metabolite, 11-nor-Δ 8 -THC-9-COOH, were 96.6 and 88.2%, respectively. The lower limits of quantification (LLOQ) for Δ 8 -THC and 11-nor-Δ 8 -THC-9-COOH were 3.97 and 7.26 nM, respectively. The topical treatment steady-state plasma concentrations of Δ 8 -THC and 11-nor-Δ 8 -THC-9-COOH were 8.24–27.63 and 19.66–23.17 nM, respectively, with a lag period of 0.3–2.2 h. This assay method is selective, sensitive, and reproducible for the determination of Δ 8 -THC and 11-nor-Δ 8 -THC-9-COOH at low concentrations in small volumes of plasma.

[1]  R. Foltz,et al.  Quantitative measurement of Δ9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry , 1983 .

[2]  R. Razdan,et al.  Structure-activity relationships of the cannabinoids. , 1986, NIDA research monograph.

[3]  S. Szidat,et al.  Enhanced selectivity in the determination of delta9-tetrahydrocannabinol and two major metabolites in serum using ion-trap GC-MS-MS. , 2000, Journal of analytical toxicology.

[4]  W. Weinmann,et al.  Simultaneous determination of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy- Δ9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry , 2004 .

[5]  A. Stinchcomb,et al.  Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  S. Pollak,et al.  Fast confirmation of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). , 2001, Forensic science international.

[7]  M. Welch,et al.  Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. , 2000, Journal of analytical toxicology.

[8]  T. Breindahl,et al.  Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[9]  R. Mechoulam,et al.  An efficient new cannabinoid antiemetic in pediatric oncology. , 1995, Life sciences.

[10]  M. Hanke,et al.  Routine-Nachweis des THC-Metaboliten 11-Nor-Δ9-tetrahydrocannabinol-9-carbonsäure in der forensischen Praxis , 2005, Zeitschrift für Rechtsmedizin.

[11]  D. Crockett,et al.  Solid-phase extraction of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid from urine drug-testing specimens with the cerex polycrom-THC column. , 2000, Journal of analytical toxicology.

[12]  S. Almog,et al.  Transdermal delivery of tetrahydrocannabinol , 1988 .